Takaisin Tulosta

Sydämen vajaatoiminta, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
19.12.2023

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Sydämen vajaatoiminta «Sydämen vajaatoiminta»1näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Abraham WT, Young JB, León AR, ym. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure. Circulation 2004;110(18):2864-8 «PMID: 15505095»PubMed
  2. Anker SD, Butler J, Filippatos G, ym. Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med 2021;385(16):1451-1461 «PMID: 34449189»PubMed
  3. Anker SD, Comin Colet J, Filippatos G, ym. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361(25):2436-48 «PMID: 19920054»PubMed
  4. Anker SD, Ponikowski P, Khan MS, ym. Responder analysis for improvement in 6-min walk test with ferric carboxymaltose in patients with heart failure with reduced ejection fraction and iron deficiency. Eur J Heart Fail 2022;24(5):833-842 «PMID: 35334136»PubMed
  5. Ashenden R, Silagy C, Weller D. A systematic review of the effectiveness of promoting lifestyle change in general practice. Fam Pract 1997;14(2):160-76 «PMID: 9137956»PubMed
  6. Ballesteros J, Duffy JC, Querejeta I, ym. Efficacy of brief interventions for hazardous drinkers in primary care: systematic review and meta-analyses. Alcohol Clin Exp Res 2004;28(4):608-18 «PMID: 15100612»PubMed
  7. Ballesteros J, González-Pinto A, Querejeta I, ym. Brief interventions for hazardous drinkers delivered in primary care are equally effective in men and women. Addiction 2004;99(1):103-8 «PMID: 14678068»PubMed
  8. Beich A, Thorsen T, Rollnick S. Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis. BMJ 2003;327(7414):536-42 «PMID: 12958114»PubMed
  9. Bertholet N, Daeppen JB, Wietlisbach V, ym. Reduction of alcohol consumption by brief alcohol intervention in primary care: systematic review and meta-analysis. Arch Intern Med 2005;165(9):986-95 «PMID: 15883236»PubMed
  10. Bhatt DL, Szarek M, Steg PG, ym. Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure. N Engl J Med 2021;384(2):117-128 «PMID: 33200892»PubMed
  11. Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction 1993;88(3):315-35 «PMID: 8461850»PubMed
  12. Brignole M, Gianfranchi L, Menozzi C, ym. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation 1997;96(8):2617-24 «PMID: 9355902»PubMed
  13. Brignole M, Menozzi C, Gianfranchi L, ym. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1998;98(10):953-60 «PMID: 9737514»PubMed
  14. Brignole M, Pokushalov E, Pentimalli F, ym. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. Eur Heart J 2018;39(45):3999-4008 «PMID: 30165479»PubMed
  15. Brophy JM, Joseph L, Rouleau JL. Beta-blockers in congestive heart failure. A Bayesian meta-analysis. Ann Intern Med 2001;134(7):550-60 «PMID: 11281737»PubMed
  16. Butler J, Khan MS, Friede T, ym. Health status improvement with ferric carboxymaltose in heart failure with reduced ejection fraction and iron deficiency. Eur J Heart Fail 2022;24(5):821-832 «PMID: 35279929»PubMed
  17. Calkins H, Reynolds MR, Spector P, ym. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009;2(4):349-61 «PMID: 19808490»PubMed
  18. Chang G, McNamara TK, Orav EJ, ym. Brief intervention for prenatal alcohol use: a randomized trial. Obstet Gynecol 2005;105(5 Pt 1):991-8 «PMID: 15863535»PubMed
  19. Chatterjee S, Biondi-Zoccai G, Abbate A, ym. Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis. BMJ 2013;346():f55 «PMID: 23325883»PubMed
  20. Chen F, Zhou Y, Wan Q, ym. Effect of non-vitamin K antagonist oral anticoagulants versus warfarin in heart failure patients with atrial fibrillation. Heart Fail Rev 2021;26(6):1391-1397 «PMID: 32249407»PubMed
  21. Cleland JG, Abraham WT, Linde C, ym. An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure. Eur Heart J 2013;34(46):3547-56 «PMID: 23900696»PubMed
  22. Cleland JG, Daubert JC, Erdmann E, ym. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27(16):1928-32 «PMID: 16782715»PubMed
  23. Cleland JG, Tendera M, Adamus J, ym. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006;27(19):2338-45 «PMID: 16963472»PubMed
  24. Colin-Ramirez E, Sepehrvand N, Rathwell S, ym. Sodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Circ Heart Fail 2023;16(1):e009879 «PMID: 36373551»PubMed
  25. Cuijpers P, Riper H, Lemmers L. The effects on mortality of brief interventions for problem drinking: a meta-analysis. Addiction 2004;99(7):839-45 «PMID: 15200579»PubMed
  26. D'Onofrio G, Pantalon MV, Degutis LC, ym. Brief intervention for hazardous and harmful drinkers in the emergency department. Ann Emerg Med 2008;51(6):742-750.e2 «PMID: 18436340»PubMed
  27. Doshi RN, Daoud EG, Fellows C, ym. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16(11):1160-5 «PMID: 16302897»PubMed
  28. Drews TEI, Laukkanen J, Nieminen T. Non-invasive home telemonitoring in patients with decompensated heart failure: a systematic review and meta-analysis. ESC Heart Fail 2021;8(5):3696-3708 «PMID: 34165912»PubMed
  29. Edwards JJ, O'Driscoll JM. Exercise Training in Heart failure with Preserved and Reduced Ejection Fraction: A Systematic Review and Meta-Analysis. Sports Med Open 2022;8(1):76 «PMID: 35674912»PubMed
  30. Egídio de Sousa I, Pedroso A, Chambino B, ym. Palliative Care in Heart Failure: Challenging Prognostication. Cureus 2021;13(9):e18301 «PMID: 34722076»PubMed
  31. Emmen MJ, Schippers GM, Bleijenberg G, ym. Effectiveness of opportunistic brief interventions for problem drinking in a general hospital setting: systematic review. BMJ 2004;328(7435):318 «PMID: 14729657»PubMed
  32. Eurich DT, Weir DL, Majumdar SR, ym. Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients. Circ Heart Fail 2013;6(3):395-402 «PMID: 23508758»PubMed
  33. Ezekowitz JA, Colin-Ramirez E, Ross H, ym. Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial. Lancet 2022;399(10333):1391-1400 «PMID: 35381194»PubMed
  34. Ezekowitz JA, McAlister FA. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. Eur Heart J 2009;30(4):469-77 «PMID: 19066207»PubMed
  35. Felker GM, Anstrom KJ, Adams KF, ym. Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. JAMA 2017;318(8):713-720 «PMID: 28829876»PubMed
  36. Ferreira AM, Adragão P, Cavaco DM, ym. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Europace 2008;10(7):809-15 «PMID: 18511438»PubMed
  37. Flather MD, Yusuf S, Køber L, ym. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355(9215):1575-81 «PMID: 10821360»PubMed
  38. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 1995;273(18):1450-6 «PMID: 7654275»PubMed
  39. Gasparini M, Auricchio A, Regoli F, ym. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 2006;48(4):734-43 «PMID: 16904542»PubMed
  40. Gasparini M, Leclercq C, Lunati M, ym. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry). JACC Heart Fail 2013;1(6):500-7 «PMID: 24622002»PubMed
  41. Graham FJ, Pellicori P, Kalra PR, ym. Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. Eur J Heart Fail 2023;25(4):528-537 «PMID: 36823953»PubMed
  42. Harwood AE, Russell S, Okwose NC, ym. A systematic review of rehabilitation in chronic heart failure: evaluating the reporting of exercise interventions. ESC Heart Fail 2021;8(5):3458-3471 «PMID: 34235878»PubMed
  43. Heran BS, Musini VM, Bassett K, ym. Angiotensin receptor blockers for heart failure. Cochrane Database Syst Rev 2012;2012(4):CD003040 «PMID: 22513909»PubMed
  44. Hu LJ, Chen YQ, Deng SB, ym. Additional use of an aldosterone antagonist in patients with mild to moderate chronic heart failure: a systematic review and meta-analysis. Br J Clin Pharmacol 2013;75(5):1202-12 «PMID: 23088367»PubMed
  45. Huang W, Su L, Wu S, ym. Benefits of Permanent His Bundle Pacing Combined With Atrioventricular Node Ablation in Atrial Fibrillation Patients With Heart Failure With Both Preserved and Reduced Left Ventricular Ejection Fraction. J Am Heart Assoc 2017;6(4): «PMID: 28365568»PubMed
  46. Inglis SC, Clark RA, Dierckx R, ym. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015;2015(10):CD007228 «PMID: 26517969»PubMed
  47. Inglis SC, Clark RA, Dierckx R ym. Structured telephone support or telemonitoring programmes for patients with chronic heart failure: systematic review and meta-analysis. Eur J Heart Fail 2020;22:891-901; PMID: 32024668
  48. Jankowska EA, Kirwan BA, Kosiborod M, ym. The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. Eur Heart J 2021;42(31):3011-3020 «PMID: 34080008»PubMed
  49. Jin H, Zhu K, Wang L, ym. Efficacy and safety of non-vitamin K anticoagulants and warfarin in patients with atrial fibrillation and heart failure: A network meta-analysis. Thromb Res 2020;196():109-119 «PMID: 32861151»PubMed
  50. Kahan M, Wilson L, Becker L. Effectiveness of physician-based interventions with problem drinkers: a review. CMAJ 1995;152(6):851-9 «PMID: 7697578»PubMed
  51. Kalra PR, Cleland JGF, Petrie MC, ym. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet 2022;400(10369):2199-2209 «PMID: 36347265»PubMed
  52. Kaner EF, Beyer F, Dickinson HO, ym. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev 2007;(2):CD004148 «PMID: 17443541»PubMed
  53. Kaner EF, Dickinson HO, Beyer F, ym. The effectiveness of brief alcohol interventions in primary care settings: a systematic review. Drug Alcohol Rev 2009;28(3):301-23 «PMID: 19489992»PubMed
  54. Kay GN, Ellenbogen KA, Giudici M, ym. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators. J Interv Card Electrophysiol 1998;2(2):121-35 «PMID: 9870004»PubMed
  55. Kotecha D, Holmes J, Krum H, ym. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 2014;384(9961):2235-43 «PMID: 25193873»PubMed
  56. Køber L, Thune JJ, Nielsen JC, ym. Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure. N Engl J Med 2016;375(13):1221-30 «PMID: 27571011»PubMed
  57. Lee TC, Qian M, Lip GYH, ym. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial). Am J Cardiol 2018;122(5):821-827 «PMID: 30037426»PubMed
  58. Li W, Seo J, Kokkinidis DG, ym. Efficacy and safety of vitamin-K antagonists and direct oral anticoagulants for stroke prevention in patients with heart failure and sinus rhythm: An updated systematic review and meta-analysis of randomized clinical trials. Int J Stroke 2023;18(4):392-399 «PMID: 35689348»PubMed
  59. Linde C, Abraham WT, Gold MR, ym. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52(23):1834-1843 «PMID: 19038680»PubMed
  60. Liu F, Chen Y, Feng X, ym. Effects of beta-blockers on heart failure with preserved ejection fraction: a meta-analysis. PLoS One 2014;9(3):e90555 «PMID: 24599093»PubMed
  61. Mark DB, Cowper PA, Anstrom KJ, ym. Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure. J Am Coll Cardiol 2018;72(21):2551-2562 «PMID: 30466512»PubMed
  62. Marrouche NF, Brachmann J, Andresen D, ym. Catheter Ablation for Atrial Fibrillation with Heart Failure. N Engl J Med 2018;378(5):417-427 «PMID: 29385358»PubMed
  63. Martin N, Manoharan K, Davies C, ym. Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. Cochrane Database Syst Rev 2021;5(5):CD012721 «PMID: 34022072»PubMed
  64. Massie BM, Carson PE, McMurray JJ, ym. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359(23):2456-67 «PMID: 19001508»PubMed
  65. McDonagh TA, Metra M, Adamo M, ym. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42(36):3599-3726 «PMID: 34447992»PubMed
  66. McMurray JJV, Solomon SD, Inzucchi SE, ym. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med 2019;381(21):1995-2008 «PMID: 31535829»PubMed
  67. McQueen J, Howe TE, Allan L, ym. Brief interventions for heavy alcohol users admitted to general hospital wards. Cochrane Database Syst Rev 2011;2011(8):CD005191 «PMID: 21833953»PubMed
  68. Mdege ND, Fayter D, Watson JM, ym. Interventions for reducing alcohol consumption among general hospital inpatient heavy alcohol users: a systematic review. Drug Alcohol Depend 2013;131(1-2):1-22 «PMID: 23474201»PubMed
  69. Mehra MR, Vaduganathan M, Fu M, ym. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Eur Heart J 2019;40(44):3593-3602 «PMID: 31461239»PubMed
  70. Mentz RJ, Garg J, Rockhold FW, ym. Ferric Carboxymaltose in Heart Failure with Iron Deficiency. N Engl J Med 2023;389(11):975-986 «PMID: 37632463»PubMed
  71. Moyer A, Finney JW, Swearingen CE, ym. Brief interventions for alcohol problems: a meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 2002;97(3):279-92 «PMID: 11964101»PubMed
  72. Nilsen P, Baird J, Mello MJ, ym. A systematic review of emergency care brief alcohol interventions for injury patients. J Subst Abuse Treat 2008;35(2):184-201 «PMID: 18083321»PubMed
  73. O'Connor MJ, Whaley SE. Brief intervention for alcohol use by pregnant women. Am J Public Health 2007;97(2):252-8 «PMID: 17194863»PubMed
  74. O'Donnell A, Anderson P, Newbury-Birch D, ym. The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. Alcohol Alcohol 2014;49(1):66-78 «PMID: 24232177»PubMed
  75. Packer DL, Piccini JP, Monahan KH, ym. Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial. Circulation 2021;143(14):1377-1390 «PMID: 33554614»PubMed
  76. Packer M, Anker SD, Butler J, ym. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med 2020;383(15):1413-1424 «PMID: 32865377»PubMed
  77. Pappone C, Rosanio S, Augello G, ym. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003;42(2):185-97 «PMID: 12875749»PubMed
  78. Parkash R, Wells GA, Rouleau J, ym. Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial. Circulation 2022;145(23):1693-1704 «PMID: 35313733»PubMed
  79. Pfeffer MA, Claggett B, Assmann SF, ym. Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial. Circulation 2015;131(1):34-42 «PMID: 25406305»PubMed
  80. Piccini JP, Lopes RD, Kong MH, ym. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009;2(6):626-33 «PMID: 20009077»PubMed
  81. Pitt B, Pfeffer MA, Assmann SF, ym. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 2014;370(15):1383-92 «PMID: 24716680»PubMed
  82. Pitt B, Remme W, Zannad F, ym. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348(14):1309-21 «PMID: 12668699»PubMed
  83. Pitt B, Zannad F, Remme WJ, ym. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341(10):709-17 «PMID: 10471456»PubMed
  84. Poikolainen K. Effectiveness of brief interventions to reduce alcohol intake in primary health care populations: a meta-analysis. Prev Med 1999;28(5):503-9 «PMID: 10329341»PubMed
  85. Ponikowski P, Kirwan BA, Anker SD, ym. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 2020;396(10266):1895-1904 «PMID: 33197395»PubMed
  86. Ponikowski P, Mentz RJ, Hernandez AF, ym. Efficacy of Ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. Eur Heart J 2023;(): «PMID: 37632415»PubMed
  87. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, ym. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. Eur Heart J 2015;36(11):657-68 «PMID: 25176939»PubMed
  88. Riper H, van Straten A, Keuken M, ym. Curbing problem drinking with personalized-feedback interventions: a meta-analysis. Am J Prev Med 2009;36(3):247-55 «PMID: 19215850»PubMed
  89. Rogers JG, Patel CB, Mentz RJ, ym. Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial. J Am Coll Cardiol 2017;70(3):331-341 «PMID: 28705314»PubMed
  90. Sahlollbey N, Lee CKS, Shirin A, ym. The impact of palliative care on clinical and patient-centred outcomes in patients with advanced heart failure: a systematic review of randomized controlled trials. Eur J Heart Fail 2020;22(12):2340-2346 «PMID: 32176831»PubMed
  91. Saitz R. Alcohol screening and brief intervention in primary care: Absence of evidence for efficacy in people with dependence or very heavy drinking. Drug Alcohol Rev 2010;29(6):631-40 «PMID: 20973848»PubMed
  92. Salaspuro M. Intervention against hazardous alcohol consumption – secondary prevention of alcohol problems. Kirjassa: Berglund M, Thelander E, Jonsson E (toim.) Treating alcohol and drug abuse p. 1-41. Wiley-VCH, Weinheim 2003
  93. Santiago de Araújo Pio C, Chaves GS, Davies P, ym. Interventions to promote patient utilisation of cardiac rehabilitation. Cochrane Database Syst Rev 2019;2(2):CD007131 «PMID: 30706942»PubMed
  94. Savarese G, Giugliano RP, Rosano GM, ym. Efficacy and Safety of Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Heart Failure: A Meta-Analysis. JACC Heart Fail 2016;4(11):870-880 «PMID: 27614940»PubMed
  95. Shantsila E, Kozieł M, Lip GY. Anticoagulation versus placebo for heart failure in sinus rhythm. Cochrane Database Syst Rev 2021;5(5):CD003336 «PMID: 34002371»PubMed
  96. Shibata MC, Flather MD, Wang D. Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure. Eur J Heart Fail 2001;3(3):351-7 «PMID: 11378007»PubMed
  97. Sohns C, Fox H, Marrouche NF, ym. Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation. N Engl J Med 2023;389(15):1380-1389 «PMID: 37634135»PubMed
  98. Solomon SD, McMurray JJV, Claggett B, ym. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med 2022;387(12):1089-1098 «PMID: 36027570»PubMed
  99. Steffel J, Robertson M, Singh JP, ym. The effect of QRS duration on cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. Eur Heart J 2015;36(30):1983-9 «PMID: 26009595»PubMed
  100. Takeda A, Martin N, Taylor RS, ym. Disease management interventions for heart failure. Cochrane Database Syst Rev 2019;1(1):CD002752 «PMID: 30620776»PubMed
  101. Tang AS, Wells GA, Talajic M, ym. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363(25):2385-95 «PMID: 21073365»PubMed
  102. Vaduganathan M, Docherty KF, Claggett BL, ym. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet 2022;400(10354):757-767 «PMID: 36041474»PubMed
  103. Vital FM, Ladeira MT, Atallah AN. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev 2013;(5):CD005351 «PMID: 23728654»PubMed
  104. Webb G, Shakeshaft A, Sanson-Fisher R, ym. A systematic review of work-place interventions for alcohol-related problems. Addiction 2009;104(3):365-77 «PMID: 19207344»PubMed
  105. Whitlock EP, Polen MR, Green CA, ym. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2004;140(7):557-68 «PMID: 15068985»PubMed
  106. Wilk AI, Jensen NM, Havighurst TC. Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers. J Gen Intern Med 1997;12(5):274-83 «PMID: 9159696»PubMed
  107. Wood MA, Brown-Mahoney C, Kay GN, ym. Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. Circulation 2000;101(10):1138-44 «PMID: 10715260»PubMed
  108. Xiong Q, Lau YC, Senoo K, ym. Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials. Eur J Heart Fail 2015;17(11):1192-200 «PMID: 26335355»PubMed
  109. Yafasova A, Butt JH, Elming MB, ym. Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality). Circulation 2022;145(6):427-436 «PMID: 34882430»PubMed
  110. Young JB, Abraham WT, Smith AL, ym. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA 2003;289(20):2685-94 «PMID: 12771115»PubMed
  111. Yusuf S, Pfeffer MA, Swedberg K, ym. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362(9386):777-81 «PMID: 13678871»PubMed
  112. Zannad F, Ferreira JP, Pocock SJ, ym. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet 2020;396(10254):819-829 «PMID: 32877652»PubMed
  113. Zannad F, McMurray JJ, Krum H, ym. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364(1):11-21 «PMID: 21073363»PubMed
Artikkelin tunnus: nix03342 (050.113)
© 2024 Suomalainen Lääkäriseura Duodecim

Käypä hoito -suositus

Anna palautetta
Linkkien värikoodit